UNSPSC 51392213: Tefazoline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51392213

Definition

This classification denotes an alpha-adrenergic agonist with the molecular formula C14H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9738II2CCH, chemically known as 2-(5,6,7,8-tetrahydro-1-naphthyl)methyl)-2-imidazolin but generally known as tefazoline, which bears US NIH Compound Identifier 163309. European Medicines Agency schedules Tefazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10865MIG.

Read the full definition

The term TEFAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). TEFAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tefazoline under HS 29332990 and SITC 51573. As of Q4 2014, TEFAZOLINE remains the US FDA Preferred Term for this commodity. Tefazoline bears US NLM identifiers UMLS ID C2699906 and NCI Concept Code C75044. SMILES: N1C(=NCC1)CC1C2CCCCC2CCC1.

About UNSPSC 51392213

UNSPSC 51392213 Tefazoline is a Commodity code that in recent state and local procurement activity covers the purchase of emergency medical supplies and pharmaceutical products, particularly naloxone and drug deactivation systems procured by county health departments and state health and human services agencies. The Seminole County, Florida IFB60459723LAS solicitation demonstrates typical buying under this code: the county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the county community health building and vendors responsible for all shipping costs. Issuing bodies under the code include county health departments and state-level health and human services commissions; the Texas Health and Human Services Commission's April 2026 RFI on direct-to-manufacturer prescription programs signals emerging state agency interest in pharmacy supply chain innovation beyond traditional wholesale channels.

Recent activity appears concentrated in Florida and Texas. Seminole County released its IFB on June 30, 2026 with a July 26, 2026 response deadline, requiring e-submission through the county's e-Procurement Portal, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and a three-month probationary period. The Texas HHS Commission's April 3, 2026 RFI sought vendor capabilities for direct contracting with self-insured employee group health plans and state agencies, asking for experience in negotiated net pricing without rebates and outcomes-based agreements. Neither opportunity specifies formal set-asides for disadvantaged enterprises. The Seminole County contract carries a two-year initial term with one-year renewal option and potential FEMA funding with Clean Air Act and Federal Water Pollution Control Act compliance requirements.

Quick answers

What is UNSPSC 51392213?

UNSPSC 51392213 is Tefazoline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51392213?

UNSPSC 51392213 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51392213

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code